Additionally, by evaluating gene signatures in terminally exhausted CD8-positive TILs from various cancer types, an effector/exhaustive/tumor-reactive profile with a co-expression pattern of CD103, TIM-3 and CXCL13 was found. The gene discussed is HAVCR2; the disease is neoplasm.